Cambridge Cognition Holdings Plc (COG.L) LSE

34.00

+0(+0.00%)

Updated at September 05 03:27PM

Currency In GBp

Cambridge Cognition Holdings Plc

Address

Tunbridge Court

Cambridge, CB25 9TU

United Kingdom of Great Britain and Northern Ireland

Phone

44 1223 810 700

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Employees

119

First IPO Date

April 18, 2013

Key Executives

NameTitlePayYear Born
Mr. John HammondCo-Founder0N/A
Ms. Francesca Cormack Ph.D.Chief Scientist & Member of Scientific Advisory Board0N/A
Mr. Alex Livingstone-LearmonthChief Commercial Officer & Acting Joint MD0N/A
Ms. Nicky AckerleyGlobal HR Director0N/A
Mr. Simon MerrittMarketing and Communications Director0N/A
Mr. Nick TaptiklisHead of Technology Strategy0N/A
Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D.Senior Consultant0N/A
Mr. Rob BakerChief Operating Officer & Acting Joint MD0N/A
Dr. Lisa Elizabeth Nolan Ph.D.Vice President Business Development01962
Prof. Barbara Sahakian FBPsS, FMedSciSenior Consultant0N/A

Description

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I–IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.